TY - JOUR
T1 - Impact of awareness of terminal illness and use of palliative care or intensive care unit on the survival of terminally ill patients with cancer
T2 - Prospective cohort study
AU - Yun, Young Ho
AU - Lee, Myung Kyung
AU - Kim, Seon Young
AU - Lee, Woo Jin
AU - Jung, Kyung Hae
AU - Do, Young Rok
AU - Kim, Samyong
AU - Heo, Dae Seog
AU - Choi, Jong Soo
AU - Park, Sang Yoon
AU - Jeong, Hyun Sik
AU - Kang, Jung Hun
AU - Kim, Si Young
AU - Ro, Jungsil
AU - Lee, Jung Lim
AU - Park, Sook Ryun
AU - Park, Sohee
PY - 2011/6/20
Y1 - 2011/6/20
N2 - Purpose: We conducted this study to evaluate the validity of the perception that awareness of their terminal prognosis and use of palliative care or nonuse of an intensive care unit (ICU) causes patients to die sooner than they would otherwise. Patients and Methods: In this prospective cohort study at 11 university hospitals and the National Cancer Center in Korea, we administered questionnaires to 619 consecutive patients immediately after they were determined by physicians to be terminally ill. We followed patients during 6 months after enrollment and assessed how their survival was affected by the disclosure of terminal illness and administration of palliative care or nonuse of the ICU. Results: In a follow-up of 481 patients and 163.8 person-years, we identified 466 deceased patients. Nineteen percent of the patients died within 1 month, while 41.3% lived for 3 months, and 17.7% lived for 6 months. Once the cancer was judged terminal, the median survival time was 69 days. On multivariate analysis, neither patient awareness of terminal status at baseline (adjusted hazard ratio [aHR], 1.20; 95% CI, 0.96 to 1.51), use of a palliative care facility (aHR, 0.96; 95% CI, 0.76 to 1.21), nor general prostration (aHR, 1.23; 95% CI, 0.96 to 1.57) was associated with reduced survival. Use of the ICU (aHR, 1.47; 95% CI, 1.06 to 2.05) and poor Eastern Cooperative Oncology Group performance status (aHR, 1.37; 95% CI, 1.10 to 1.71) were significantly associated with poor survival. Conclusion: Patients' being aware that they are dying and entering a palliative care facility or ICU does not seem to influence patients' survival.
AB - Purpose: We conducted this study to evaluate the validity of the perception that awareness of their terminal prognosis and use of palliative care or nonuse of an intensive care unit (ICU) causes patients to die sooner than they would otherwise. Patients and Methods: In this prospective cohort study at 11 university hospitals and the National Cancer Center in Korea, we administered questionnaires to 619 consecutive patients immediately after they were determined by physicians to be terminally ill. We followed patients during 6 months after enrollment and assessed how their survival was affected by the disclosure of terminal illness and administration of palliative care or nonuse of the ICU. Results: In a follow-up of 481 patients and 163.8 person-years, we identified 466 deceased patients. Nineteen percent of the patients died within 1 month, while 41.3% lived for 3 months, and 17.7% lived for 6 months. Once the cancer was judged terminal, the median survival time was 69 days. On multivariate analysis, neither patient awareness of terminal status at baseline (adjusted hazard ratio [aHR], 1.20; 95% CI, 0.96 to 1.51), use of a palliative care facility (aHR, 0.96; 95% CI, 0.76 to 1.21), nor general prostration (aHR, 1.23; 95% CI, 0.96 to 1.57) was associated with reduced survival. Use of the ICU (aHR, 1.47; 95% CI, 1.06 to 2.05) and poor Eastern Cooperative Oncology Group performance status (aHR, 1.37; 95% CI, 1.10 to 1.71) were significantly associated with poor survival. Conclusion: Patients' being aware that they are dying and entering a palliative care facility or ICU does not seem to influence patients' survival.
UR - http://www.scopus.com/inward/record.url?scp=79959287460&partnerID=8YFLogxK
U2 - 10.1200/JCO.2010.30.1184
DO - 10.1200/JCO.2010.30.1184
M3 - Article
C2 - 21576638
AN - SCOPUS:79959287460
SN - 0732-183X
VL - 29
SP - 2474
EP - 2480
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 18
ER -